Cargando…
P-1 Prognostic factors and course of myasthenia gravis
Autores principales: | Albertini, E., Martignago, S., Bisciglia, M., Bonifati, M., Ermani, M., Pegoraro, E., Angelini, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235855/ |
Ejemplares similares
-
P-4
Evaluating therapy outcome in Mysthenia
Gravis
por: Bisciglia, M., et al.
Publicado: (2011) -
Outcome measures and treatment effectiveness in late onset myasthenia gravis
por: Pasqualin, Francesca, et al.
Publicado: (2020) -
Development and validation of the Myasthenia Gravis TeleScore (MGTS)
por: Pasqualin, F., et al.
Publicado: (2022) -
Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII)
por: Pasqualin, Francesca, et al.
Publicado: (2021) -
New treatments for myasthenia: a focus on antisense oligonucleotides
por: Angelini, Corrado, et al.
Publicado: (2013)